Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA): A Study Of Personalized Diagnosis of Primary Aldosteronism With Implications For Treatment

NCT03414918 is registered in ClinicalTrials.gov with University Hospital Padova as lead sponsor.

NCT NCT03414918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA): A Study Of Personalized Diagnosis of Primary Aldosteronism With Implications For Treatment
Lead sponsor
University Hospital Padova
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2018
Completion date
January 31, 2020
Enrollment
342 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperaldosteronism